[1] IJAZ I, GILANI E, NAZIR A, et al. Detail review on chemical, physical and green synthesis, classification, characterizations and applications of nanoparticles[J]. Green Chem Lett Rev, 2020, 13(3):59-81.
[2] SAKA R, CHELLA N. Nanotechnology for delivery of natural therapeutic substances: a review[J]. Environ Chem Lett, 2021, 19(2):1097-1106.
[3] CHENG H, CUI Z, GUO S, et al. Mucoadhesive versus Mucopenetrating nanoparticles for oral delivery of insulin[J]. Acta Biomater, 2021,135:506-519.
[4] ZOU M S, ZHOU L L, QIAO Y, et al. Research progress in co-delivery of anti-multidrug resistant small RNA and anti-tumor drugs with nanocarriers [J]. Chin Pharm J(中国药学杂志), 2018, 53(19):1621-1626.
[5] LIU H, LIANG X L, JIANG Q Y, et al. Effect of gastrointestinal mucus on transmembrane drug delivery and the research progress of oral drug delivery strategies [J]. Chin Pharm J(中国药学杂志), 2022, 57(3):176-180.
[6] JAIN H, CHELLA N. Methods to improve the solubility of therapeutical natural products: a review[J]. Environ Chem Lett, 2021, 19(1):111-121.
[7] LIU J, LENG P, LIU Y J. Oral drug delivery with nanoparticles into the gastrointestinal mucosa[J]. Fund Clin Pharmacol, 2021, 35(1):86-96.
[8] KAMALY N, YAMEEN B, WU J, et al. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release[J]. Chem Rev, 2016, 116(4):2602-2663.
[9] MAHMOODI N O, GHAVIDAST A, AMIRMAHANI N. A comparative study on the nanoparticles for improved drug delivery systems[J]. J Photochem Photobiol B-Biol, 2016, 162:681-693.
[10] NELEMANS L C, GUREVICH L. Drug delivery with polymeric nanocarriers-cellular uptake mechanisms[J]. Materials, 2020,13(2):366.DOI:10.3390/ma13020366.
[11] BABADI D, DADASHZADEH S, OSOULI M, et al. Nanoformulation strategies for improving intestinal permeability of drugs: A more precise look at permeability assessment methods and pharmacokinetic properties changes[J]. J Controlled Release, 2020, 321:669-709.
[12] BELOQUI A, DES RIEUX A, PREAT V. Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier[J]. Adv Drug Deliv Rev, 2016, 106:242-255.
[13] GRADISNIK L, TRAPECAR M, RUPNIK M S, et al. HUIEC, Human intestinal epithelial cell line with differentiated properties: process of isolation and characterisation[J]. Wiener Klinische Wochenschrift, 2015, 127:S204-S209.
[14] REINHOLZ J, LANDFESTER K, MAILANDER V. The challenges of oral drug delivery via nanocarriers[J]. Drug Deliv, 2018, 25(1):1694-1705.
[15] AGRAHARI V, AGRAHARI V, MITRA A K. Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities[J]. Therapeu Deliv, 2016, 7(4):257-278.
[16] YU M R, YANG Y W, ZHU C L, et al. Advances in the transepithelial transport of nanoparticles[J]. Drug Discov Today, 2016, 21(7):1155-1161.
[17] TIAN Z H, MAI Y P, MENG T T, et al. Nanocrystals for improving oral bioavailability of drugs: intestinal transport mechanisms and influencing factors[J]. AAPS Pharmscitechnol, 2021, 22(5):179. DOI:10.1208/s12249-021-02041-7.
[18] CHEN M C, MI F L, LIAO Z X, et al. Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules[J]. Adv Drug Deliv Rev, 2013, 65(6):865-879.
[19] SINGH B, MAHARIAN S, JIANG T, et al. Combinatorial approach of antigen delivery using M cell-homing peptide and mucoadhesive vehicle to enhance the efficacy of oral vaccine[J]. Mole Pharm, 2015, 12(11):3816-3828.
[20] O′HAGAN D T. Intestinal translocation of particulates: implications for drug and antigen delivery[J]. Adv Drug Deliv Rev, 1990, 5(3):265-285.
[21] MOOR A E, HARNIK Y, BEN-MOSHE S, et al. Spatial reconstruction of single enterocytes uncovers broad zonation along the intestinal villus axis[J]. Cell, 2018, 175(4):1156. DOI:10.1016/j.cell.2018.08.063.
[22] JU Y P, GUO H, EDMAN M, et al. Application of advances in endocytosis and membrane trafficking to drug delivery[J]. Adv Drug Deliv Rev, 2020, 157:118-141.
[23] ELKIN S R, LAKODUK A M, SCHMID S L. Endocytic pathways and endosomal trafficking: a primer. [J]. Wiener Medizinische Wochenschrift (1946), 2016, 166(7/8):196-204.
[24] DONAHUE N D, ACAR H, WILHELM S. Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine[J]. Adv Drug Deliv Rev, 2019, 143:68-96.
[25] HUANG Y N, DING L, YAO C J, et al. Effect of transferrin on cellular uptake or expulsion of titanium dioxide nanoparticles[J]. Nano, 2020, 15(9):2050121. DOI:10.1142/S1793292020501210.
[26] PHUC L, TANIGUCHI A. Epidermal growth factor enhances cellular uptake of polystyrene nanoparticles by clathrin-mediated endocytosis[J]. Int J Mol Sci, 2017, 18(6):1301. DOI:10.3390/ijms18061301.
[27] PARTON R G. Caveolae: structure, function, and relationship to disease[J]. Ann Rev Cell Dev Biol, 2018, 34(1):111-136.
[28] YAMEEN B, CHOI W I, VILOS C, et al. Insight into nanoparticle cellular uptake and intracellular targeting[J]. J Controlled Release, 2014, 190:485-499.
[29] CAO D, TIAN S, HUANG H, et al. Divalent folate modification on PEG: an effective strategy for improving the cellular uptake and targetability of PEGylated polyamidoamine-polyethylenimine Copolymer[J]. Mol Pharm, 2015, 12(1):240-252.
[30] XIN X F, PEI X, YANG X, et al. Rod-shaped active drug particles enable efficient and safe gene delivery[J]. Adv Sci, 2017, 4(11):1700324. DOI:10.1002/advs.201700324.
[31] KUMARI S, SWETHA M G, MAYOR S. Endocytosis unplugged: multiple ways to enter the cell[J]. Cell Res, 2010, 20(3):256-275.
[32] CAVANAUGH K E, STADDON M F, MUNRO E, et al. RhoA mediates epithelial cell shape changes via mechanosensitive endocytosis[J]. Dev Cell, 2020, 52(2):152-166.
[33] CASAMENTO A, BOUCROT E. Molecular mechanism of Fast Endophilin-Mediated Endocytosis[J]. Biochem J, 2020, 477(12):2327-2345.
[34] DAY C A, BAETZ N W, COPELAND C A, et al. Microtubule motors power plasma membrane tubulation in clathrin-independent endocytosis[J]. Traffic, 2015, 16(6):572-590.
[35] VAN ACKER T, TAVERNIER J, PEELMAN F. The small GTPase Arf6: an overview of its mechanisms of action and of its role in host-pathogen interactions and innate immunity[J]. Int J Mol Sci, 2019, 20(9):2209. DOI:10.3390/ijms20092209.
[36] THOTTACHERRY J J, KOSMALSKA A J, KUMAR A, et al. Mechanochemical feedback control of dynamin independent endocytosis modulates membrane tension in adherent cells[J]. Nat Commun, 2018: 4217. DOI:10.1038/S41467-018-06738-5.
[37] JOSEPH J G, LIU A P. Mechanical regulation of endocytosis: new insights and recent advances[J]. Adv Biosys, 2020, 4(5):1900278. DOI:10.1002/adbi.201900278.
[38] CANTON J. Macropinocytosis: new insights into its underappreciated role in innate immune cell surveillance[J]. Front Immunol, 2018, 9:2286. DOI:10.3389/fimmu.2018.02286.
[39] BUCKLEY C M, KING J S. Drinking problems: mechanisms of macropinosome formation and maturation[J]. Febs J, 2017, 284(22):3778-3790.
[40] MEANS N, ELECHALAWAR C K, CHEN W R, et al. Revealing macropinocytosis using nanoparticles[J]. Mol Asp Med, 2022, 83:100993. DOI:10.1016/j.mam.2021.100993.
[41] LI Y X, PANG H B. Macropinocytosis as a cell entry route for peptide-functionalized and bystander nanoparticles[J]. J Controlled Release, 2021, 329:1222-1230.
[42] YHEE J Y, YOON H Y, KIM H, et al. The effects of collagen-rich extracellular matrix on the intracellular delivery of glycol chitosan nanoparticles in human lung fibroblasts[J]. Int J Nanomed, 2017, 12:6089-6105.
[43] SHILPI D, KUSHWAH V, AGRAWAL A K, et al. Improved Stability and Enhanced Oral Bioavailability of Atorvastatin Loaded Stearic Acid Modified Gelatin Nanoparticles[J]. Pharm Res, 2017, 34(7):1505-1516.
[44] ARAI M, KOMORI H, FUJITA D, et al. Uptake Pathway of Apple-derived Nanoparticle by Intestinal Cells to Deliver its Cargo[J]. Pharm Res, 2021, 38(3):523-530.
[45] ZHANG J, FIELD C J, VINE D, et al. Intestinal Uptake and Transport of Vitamin B-12-loaded Soy Protein Nanoparticles[J]. Pharm Res, 2015, 32(4):1288-1303.
[46] LIU G Y, ZHOU Y, CHEN L Y. Intestinal uptake of barley protein-based nanoparticles for beta-carotene delivery[J]. Acta Pharm Sin B(药学学报 英文), 2019, 9(1):87-96.
[47] DOU T Y, WANG J, HAN C K, et al. Cellular uptake and transport characteristics of chitosan modified nanoparticles in Caco-2 cell monolayers[J]. Int J Biol Macromole, 2019, 138:791-799.
[48] PATEL M, MUNDADA V, SAWANT K. Enhanced intestinal absorption of asenapine maleate by fabricating solid lipid nanoparticles using TPGS: elucidation of transport mechanism, permeability across Caco-2 cell line and in vivo pharmacokinetic studies[J]. Artficial Cells Nanomed Biotechnol, 2019, 47(1):144-153.
[49] LI Q, LIU C G, YU Y. Separation of monodisperse alginate nanoparticles and effect of particle size on transport of vitamin E[J]. Carbohydr Poly, 2015, 124:274-279.
[50] PENG Y Q, LI X Q, GU P X, et al. Curcumin-loaded zein/pectin nanoparticles: Caco-2 cellular uptake and the effects on cell cycle arrest and apoptosis of human hepatoma cells (HepG2)[J]. J Drug Deliv Sci Technol, 2022, 74:103497. DOI:10.1016/j.jddst.2022.103497.
[51] HE B, JIA Z R, DU W W, et al. The transport pathways of polymer nanoparticles in MDCK epithelial cells[J]. Biomaterials, 2013, 34(17):4309-4326.
[52] AKBARI A, LAVASANIFAR A, WU J P. Interaction of cruciferin-based nanoparticles with Caco-2 cells and Caco-2/HT29-MTX co-cultures[J]. Acta Biomater, 2017, 64:249-258.
[53] SONG H D, HE A J, GUAN X, et al. Fabrication of chitosan-coated epigallocatechin-3-gallate (EGCG)-hordein nanoparticles and their transcellular permeability in Caco-2/HT29 cocultures[J]. Int J Biol Macromole, 2022, 196:144-150.
[54] PARVEZ S, KAROLE A, MUDAVATH S L. Transport mechanism of hydroxy-propyl-beta-cyclodextrin modified solid lipid nanoparticles across human epithelial cells for the oral absorption of antileishmanial drugs[J]. Biochimica Et Biophysica Acta-General Subjects, 2022, 1866(8):130157. DOI:10.1016/j.bbagen.2022.130157.
[55] VILLASENOR R, LAMPE J, SCHWANINGER M, et al. Intracellular transport and regulation of transcytosis across the blood-brain barrier[J]. Cellular Mol Life Sci 2019, 76(6):1081-1092.
[56] BEHZADI S, SERPOOSHAN V, TAO W, et al. Cellular uptake of nanoparticles: journey inside the cell[J]. Chem Soc Rev, 2017, 46(14):4218-4244.
[57] NASLAVSKY N, CAPLAN S. The enigmatic endosome-sorting the ins and outs of endocytic trafficking[J]. J Cell Sci, 2018, 131(13): JCS216499. DOI:10.1242/jcs.216499.
[58] ZHANG J X, CHANG D F, YANG Y, et al. Systematic investigation on the intracellular trafficking network of polymeric nanoparticles[J]. Nanoscale, 2017, 9(9):3269-3282.
[59] YUAN W, SONG C. The Emerging Role of Rab5 in Membrane Receptor Trafficking and Signaling Pathways. [J]. Biochem Res Int, 2020, 2020:4186308. DOI:10.1155/2020/4186308.
[60] ZEIGERER A, GILLERON J, BOGORAD R L, et al. Rab5 is necessary for the biogenesis of the endolysosomal system in vivo[J]. Nature, 2012, 485(7399):465-470.
[61] MAJZOUB R N, CHAN C L, EWERT K K, et al. Fluorescence microscopy colocalization of lipid-nucleic acid nanoparticles with wildtype and mutant Rab5-GFP: A platform for investigating early endosomal events[J]. Biochimica Et Biophysica Acta-Biomembranes, 2015, 1848(6):1308-1318.
[62] GRANT B D, DONALDSON J G. Pathways and mechanisms of endocytic recycling[J]. Nat Rev Mol Cell Biol, 2009, 10(9):597-608.
[63] BAY A, SCHREINER R, BENEDICTO I, et al. The fast-recycling receptor Megalin defines the apical recycling pathway of epithelial cells[J]. Nat Commun, 2016, 7: 11550. DOI:10.1038/ncomms11550.
[64] IRABUTU M J, GARNER T, MONTIEL-DUARTE C. Revising Endosomal Trafficking under Insulin Receptor Activation[J]. Int J Mol Sci, 2021, 22(13): 6978. DOI:10.3390/ijms22136978.
[65] REDPATH G, BETZLER V M, ROSSATTI P, et al. Membrane Heterogeneity Controls Cellular Endocytic Trafficking[J]. Front Cell Dev Biol, 2020, 8: 757. DOI:10.3389/fcell.2020.00757.
[66] TAGUCHI T. Emerging roles of recycling endosomes[J]. J Biochem, 2013, 153(6):505-510.
[67] CHRIST L, RAIBORG C, WENZEL E M, et al. Cellular Functions and Molecular Mechanisms of the ESCRT Membrane-Scission Machinery[J]. Trends Biochem Sci, 2017, 42(1):42-56.
[68] GRUENBURG J. Life in the lumen: The multivesicular endosome[J]. Traffic, 2020, 21(1):76-93.
[69] CRUZ D L, PIPALIA N, MAO S, et al. Inhibition of Histone Deacetylases 1, 2, and 3 Enhances Clearance of Cholesterol Accumulation in Niemann-Pick C1 Fibroblasts [J]. ACS pharmacol Transl Sci, 2021, 4(3):1136-1148.
[70] OSTROWSKI M, CARMO N B, KRUMEICH S, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway[J]. Nat Cell Biol, 2010, 12(1):19-61.
[71] CHOU L, MING K, CHAN W. Strategies for the intracellular delivery of nanoparticles[J]. Chem Socy Revs, 2011, 40(1):233-245.
[72] WANG T R, LUO Y C. Biological fate of ingested lipid-based nanoparticles: current understanding and future directions[J]. Nanoscale, 2019, 11(23):11048-11063.
[73] CHAI G H, XU Y K, CHEN S Q, et al. Transport Mechanisms of Solid Lipid Nanoparticles across Caco-2 Cell Monolayers and their Related Cytotoxicology[J]. ACS Appl Mater Interfaces, 2016, 8(9):5929-5940.
[74] HE B, LIN P, JIA Z R, et al. The transport mechanisms of polymer nanoparticles in Caco-2 epithelial cells[J]. Biomaterials, 2013, 34(25):6082-6098.
[75] SALAH E, ABOUELFETOUH M M, PAN Y H, et al. Solid lipid nanoparticles for enhanced oral absorption: a review[J]. Colloids Surfaces B-Biointerfaces, 2020, 196:111305. DOI:10.1016/j.colsurfb.2020.111305.
[76] WU L, BAI Y L, LIU M, et al. Transport Mechanisms of Butyrate Modified Nanoparticles: Insight into “Easy Entry, Hard Transcytosis” of Active Targeting System in Oral Administration[J]. Mol Pharm, 2018, 15(9):4273-4283.
[77] ZHUANG J, WANG D D, LI D, et al. The influence of nanoparticle shape on bilateral exocytosis from Caco-2 cells[J]. Chin Chem Lett(中国化学快报), 2018, 29(12):1815-1818.
[78] LIU X, WU R N, LI Y T, et al. Angiopep-2-functionalized nanoparticles enhance transport of protein drugs across intestinal epithelia by self-regulation of targeted receptors[J]. Biomater Sci, 2021, 9(8):2903-2916.
[79] XING L Y, ZHENG Y X, YU Y L, et al. Complying with the physiological functions of Golgi apparatus for secretory exocytosis facilitated oral absorption of protein drugs[J]. J Mater Chem B, 2021, 9(6):1707-1718.
[80] ZHANG R Y, DENG H L, LIN Y X, et al. A common strategy to improve transmembrane transport in polarized epithelial cells based on sorting signals: Guiding nanocarriers to TGN rather than to the basolateral plasma membrane directly[J]. J Controlled Release, 2021, 339:430-444.